Tichakunda Mharazanye: A New Year, New Challenges, And New Milestones
Tichakunda Mharazanye, Pharmacy student at RIMT University, shared on LinkedIn about a recent article he and his colleague co-authored, adding:
”A new year, new challenges, and new milestones
The start of this year came with its fair share of pressure, tight deadlines and moments of selfdoubt.
Staying consistent, focused and curious helped me push through and l am grateful to begin the year by sharing my latest review publication.
Our work explores hemophilia beyond clotting factors, focusing on albumin as an underappreciated prognostic and diagnostic marker.
The review highlights how albumin reflects disease burden, influences bleeding severity and joint outcomes, and plays a key role in the pharmacokinetics of modern hemophilia therapies opening doors for more personalized prophylaxis.
Grateful for the learning process, the resilience it builds, and the opportunity to contribute to advancing patient-centered care in hemophilia.”
Title: Hemophilia And Albumin: Quantitative Analysis For Prognostic And Diagnostic Applications
Authors: Tichakunda Xavier Mharazanye, Shaun Muponda
Read the Full Article on The International Journal of Engineering Development and Research
More winner stories featured in Hemostasis Today.
-
Mar 20, 2026, 17:47Julie Rayes: Commenting on a Seminal NEJM Study Solving the Mystery of VITT
-
Mar 20, 2026, 17:45William Tembo: Advancing Stroke Care by Validating Acute Ischemic Treatment
-
Mar 20, 2026, 17:37Renjith Vijayakumar Selvarani: New Nanoparticle Approach Clears Brain Plaque and Restores Memory
-
Mar 20, 2026, 17:35Bawan Ahmed: New Evidence May Shift DOAC Choice in Acute DVT Management
-
Mar 20, 2026, 17:17Angelo Cascio Rizzo: CTA-Based Plaque RADS Improves Risk Stratification in ESUS
-
Mar 20, 2026, 17:09Clinical Practice Guidelines for Platelet Transfusion in Non-Surgical and Non-Traumatic Settings – CEBaP
-
Mar 20, 2026, 17:07The Rich Heterogeneity of Platelets and Its Vital Shifts Across Disease States – RPTH
-
Mar 20, 2026, 17:05Pierre Fontana: Launching the European Interuniversity Certificate in Clinical Haemostasis
-
Mar 20, 2026, 16:49Wolfgang Miesbach: A Pivotal Step Forward for Patients with von Willebrand Disease Across All Subtypes